Breaking News Bar

Business News and Information

Aveo shares get a boost from the ‘Idenix effect’

More that a year after the high-profile FDA rejection that dashed the hopes of Aveo Pharmaceuticals to be the next commercial-stage cancer drug company in Massachusetts, some investors are starting to take a second look in the past couple weeks thanks in part to the sale of Idenix Pharmaceuticals...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear